Literature DB >> 2989687

Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity.

M Tuchman, J S Stoeckeler, D T Kiang, R F O'Dea, M L Ramnaraine, B L Mirkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989687     DOI: 10.1056/NEJM198507253130407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  36 in total

Review 1.  Role of gene expression arrays in sarcomas.

Authors:  Keith M Skubitz; Amy P N Skubitz
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

Review 2.  Inborn 'errors' of drug metabolism. Pharmacokinetic and clinical implications.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 3.  Selection of extreme phenotypes: the role of clinical observation in translational research.

Authors:  José Luis Pérez-Gracia; Alfonso Gúrpide; María Gloria Ruiz-Ilundain; Carlos Alfaro Alegría; Ramon Colomer; Jesús García-Foncillas; Ignacio Melero Bermejo
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

4.  Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.

Authors:  X Wei; H L McLeod; J McMurrough; F J Gonzalez; P Fernandez-Salguero
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  Ecogenetics, xenobiotic biochemistry and neurological disease.

Authors:  A Williams
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

Review 6.  When to investigate for purine and pyrimidine disorders. Introduction and review of clinical and laboratory indications.

Authors:  H A Simmonds; J A Duley; L D Fairbanks; M B McBride
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

7.  Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.

Authors:  R B Diasio; T L Beavers; J T Carpenter
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 8.  Pharmacogenetics: a tool for individualizing antineoplastic therapy.

Authors:  F Innocenti; L Iyer; M J Ratain
Journal:  Clin Pharmacokinet       Date:  2000-11       Impact factor: 6.447

9.  Unpredicted severe toxicity after 5-fluorouracil treatment due to dihydropyrimidine dehydrogenase deficiency.

Authors:  Jin Ho Baek; Jong Gwang Kim; Shi Nae Kim; Dong Hwan Kim; Sang Kyun Sohn; Young Jun Hong; Kyu Bo Lee
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

10.  Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics.

Authors:  Hanna K Sanoff; Howard L McLeod
Journal:  Semin Colon Rectal Surg       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.